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ABSTRACT
The transcription factor Pax6 is essential for the
development of the eyes and the central nervous
system of vertebrates and invertebrates. Pax6 con-
tainstwoDNA-bindingdomains;anN-terminalpaired
domain and a centrally located homeodomain. We
have previously shown that the vertebrate paired-
less isoform of Pax6 (Pax6DPD), and several other
homeodomain proteins, interact with the full-length
isoform of Pax6 enhancing Pax6-mediated trans-
activation from paired domain-DNA binding sites.
By mutation analyses and molecular modeling we
now demonstrate that, surprisingly, the recognition
helix for specific DNA binding of the homeodomains
of Pax6 and Chx10 interacts with the C-terminal RED
subdomain of the paired domain of Pax6. Basic resi-
dues in the recognition helix and the N-terminal arm
of the homeodomain form an interaction surface that
binds to an acidic patch involving residues in helices
1 and 2 of the RED subdomain. We used fluorescence
resonance energy transfer assays to demonstrate
such interactions between Pax6 molecules in the
nuclei of living cells. Interestingly, two mutations in
the homeodomain recognition helix, R57A and R58A,
reduced protein–protein interactions, but not DNA
bindingofPax6DPD.Thesefindingssuggestacritical
role for the recognition helix and N-terminal arm of
the paired class homeodomain in protein–protein
interactions.
INTRODUCTION
Pax6 is a highly conserved member of the Pax family of
transcription factors that plays pivotal roles during embryo-
genesis in both vertebrates and invertebrates (1,2). Pax6 con-
tains two DNA-binding domains. A ﬂexible linker region
separates the N-terminally located paired domain (PD) from
the paired type homeodomain (HD). The region C-terminal to
the HD isrich in proline, serine and threonine, andfunctions as
a transcriptional activation domain (3–7). The zebraﬁsh and
human Pax6 proteins have an overall amino acid sequence
identity of 97%, while invertebrate and mouse Pax6 proteins
show more than 90% sequence identity in the PD (8). In
vertebrates, Pax6 is expressed in the developing neuroretina
and lens of the eye, in the nasal placode, in the pancreas, in the
pituitary gland [reviewed in (8)] and in the pineal gland (9,10).
Pax6 is essential for normal development of several organs,
including the brain, the pancreas and the eye. The importance
of Pax6 in development of the eye is illustrated by the fact
that Pax6 induces ectopic eyes in ﬂies and frogs upon mis-
expression (11–13). While the homozygous Pax6 mutation is
lethal to mouse embryos, the heterozygous mutant gives the
Small eye phenotype (14). In humans, heterozygous mutations
cause aniridia and are also associated with Peters anomaly and
other congenital eye disorders (15).
The paired class HDs are able to bind cooperatively to
palindromic DNA sequences of the type TAAT(N)2–3ATTA,
named P2 or P3 after the number of base pairs separating the
two TAAT/ATTA palindromic core sequences (16). The HD
of Pax6 binds preferentially to P3 sites (5). In contrast to the
cooperative DNA binding/dimerization of other HDs (e.g.
Hox), which relies onsequences extrinsic tothe HD, the paired
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achieve cooperativity upon DNA binding (16).
Several isoforms of Pax6 have been reported (17–19). One
of these is the 33/32 kDa Pax6DPD isoform that lacks the
PD owing to the use of an internal start codon for translation
between the PD and the HD (18). An alternatively spliced
PD-less isoform of Pax6 has also been isolated from mouse
brain cDNA (20). The Pax6DPD isoform is able to interact
with full-length Pax6 thereby enhancing Pax6 transactivation
from PD-binding sites in reporter gene assays (21). The HD of
Pax6DPD can interact with both the HD and the PD of Pax6.
We found that the HDs of a number of other homeodomain
proteins are also able to interact with Pax6 (21). Several other
proteins have been shown to bind to Pax proteins via the PD
and/or the HD leading to either repression or activation in
reporter gene assays (22–32).
Here, we have investigated the DNA-independent inter-
actions between the PD and the HD of Pax6 and between
the PD of Pax6 and the HD of the paired class homeodomain
protein Chx10. Surprisingly, helix 3 of the HD, which is the
recognition helix for speciﬁc DNA binding, also mediates the
protein–protein interactions with the Pax6 PD. Basic residues
on one side of helix 3 interact with acidic residues in the RED
subdomain of the PD. R3 and R5 in the N-terminal arm of the
HD also contribute to the HD–PD interaction. R57 and R58
in the Pax6 HD are important for the protein–protein interac-
tion with the PD, but they are not important for DNA binding.
Our results suggest that protein–protein interactions involving
the DNA-binding domains of Pax6 and paired-type homeo-
domain proteins may be instrumental in regulating the activity
of these transcription factors.
MATERIALS AND METHODS
Plasmid constructions
All Pax6 constructs used in this work are derived from
the zebraﬁsh Pax6.1 cDNA (33). The GST Pax6 HD, GST
Pax6 RED, GST Chx10 HD, HA-Pax6, HA-Pax6DHD,
HA-Pax6DPD HA-Pax6DPDDHD, HA-Chx10, pCI-Pax6 and
P6CON-LUC constructs have been described previously
(12,21). To construct pGST-18L-HD, a 296 bp EcoRI–XhoI
PCR fragment encoding 18 amino acids of the linker region
and the homeodomain of zebraﬁsh Pax6 (amino acids
211–309) was ampliﬁed from pCI-Pax6 using the primers
zf.pax6-HD5.50 and zf.pax6-HD5.30 and inserted into the
EcoRI–XhoI sites of pGEX-4T3. HA-Pax6DHDh2-3 was
constructed by ligation of the PCR product obtained from
HA-Pax6 using primers delB and delD. HA-Pax6DHDh2-3
was then used as template with 6DPD.HA.5 and 6.HA.3 as
primers to construct HA-Pax6DPDDh2-3 following the same
procedureasdescribedpreviouslyforHA-Pax6DPDDHD(21).
HA-Pax6DPDDh3 was constructed similarly using delC and
delD primers with HA-Pax6Dh2-3 as template. The delD,
6DPD.HA.5 and 6.HA.3 primers have been described previ-
ously (21). The 5xHDp3-LUC reporter plasmid was construc-
ted by replacing the GAL4-binding sites in pG5E1b-LUC (34)
with ﬁve copies of a homeodomain p3 site. Oligonucleotides
PaxHD-P3.1 (50-GATCCTCTAGATAATGCGATTAGCGT-
AG-30) and PaxHD-P3.2 (50-GATCCTACGCTAATCGCAT-
TATCTAGAG-30) were annealed and ﬁve copies were cloned
into the BamHI site of pUC19 making pUC19-5xHDp3. The
HDp3 sites were then cloned into the pG5E1b-LUC vector
by ligation of a 150 bp SmaI–XbaI fragment from pUC19-
5xHDp3 to HindIII(end-ﬁlled)–XbaI cut pG5E1b-LUC.
The yeast expression vector pSOS (Stratagene) contains
human SOS (residues 1–1066), the constitutive ADH1-
promoter and the LEU2 gene. To generate the bait plasmid
pSOS-zfPax6-HD, a 222 bp BamHI–SacI PCR fragment
encoding the homeodomain of zebraﬁsh Pax6 (amino acids
222–296) was ampliﬁed from pCI-Pax6 using the primers
zf-pax6-HD1-50 and zf-pax6-HD1-30 and inserted into the
BamHI–SacI sites of pSOS. Expression of the SOS–zfPax6-
HD fusion protein in transformed cdc25-2 yeast cells was
conﬁrmed by immunoblotting with an anti-SOS1 speciﬁc anti-
body (Transduction Laboratories). The pMYR expression vec-
tor (Stratagene) contains the v-Src myristoylation sequence,
the inducibleGAL1-promoter andtheURA3 gene.ThepMYR-
zfPax6-HD target vector was constructed by inserting a 222 bp
EcoRI–SalI fragment, encoding the zfPax6 homeodomain
(amino acids 222–296), ampliﬁed from pCI-Pax6 by PCR
using the primer pairs zf.pax6-HD2-50 and zf-pax6-HD2-30
and inserted into the EcoRI–SalI sites in pMYR. The
pMYR–zfPax6-PD fusion construct was made by PCR amp-
liﬁcation of the zebraﬁsh Pax6.1 paired domain (amino acids
21–154) from pCI-Pax6 using the primer pairs zf-pax6-PD2-50
and zf-pax6-PD2-30. The resulting 402 bp SmaI–SalI fragment
was ligated into the SmaI–SalI sites of pMYR. The pSOS
and pMYR constructs were veriﬁed by sequencing using
the primers 50-SOS and 50-MYR, respectively.
The Gateway cloning system (Invitrogen) was used to make
expression constructs for FRET experiments. Pax6 cDNAs
were initially subcloned into entry vectors, and subsequently
transferred into the destination vectors pDEST-EYFP-N1
and pDEST-ECFP-C1 (35). pDEST-EYFP-N1 and pDEST-
ECFP-C1 contain a C-terminal yellow ﬂuorescent protein
(YFP) and an N-terminal cyan ﬂuorescent protein (CFP),
respectively. To generate pENTR1A-Pax6DHD, a 1.0 kb
XhoI–NotI PCR fragment encoding the zebraﬁsh Pax6.1
cDNA sequence lacking the homeodomain was ampliﬁed
from HA.Pax6DHD using the primers Flag P6.50 and
PAX6.30NOTI, and inserted into the XhoI–NotI sites of
pENTR1A. pENTR1A-Pax6 was constructed by inserting a
1.3 kb XhoI–NotI fragment, encoding the full-length Pax6.1
cDNA ampliﬁed frompCI-Pax6 by PCRusingthe primerpairs
Flag P6.50 and PAX6.30NOTI, into the XhoI–NotI sites of
pENTR1A. The pENTR2B-Pax6DPD construct was made
by inserting a 900 bp EcoRI–NotI cut PCR fragment from
HA.Pax6DPD, made with primers FlagDPD.50 and PAX6.30
NOTI, into the EcoRI–NotI sites of pENTR2B. To make
pENTR11-Pax6, the full-length Pax6.1 coding sequence
was ampliﬁed from pCI-Pax6 using Pfu polymerase and the
primers Flag P6.50 and P630Ustopp, and the resulting 1.3 kb
PCR product was inserted into the XhoI–NotI sites of
pENTR11. pENTR3C-zfPax6HDwas constructedbyinserting
a 200 bp fragment encoding the homeodomain from Pax6.1
cDNA into the EcoRI–XhoI sites of pENTR3C. The entry
vector pENTR1A-Pax6DPD (R53A.R57A) was made by
PCR ampliﬁcation of a 900 bp fragment from HA.Pax6DPD
(R53A.R57A) using the primer pairs zf.pax6.HD7-50 and
zf.pax6.TAD2-30. The 900 bp Pax6.1 cDNA sequence lacking
the paired domain was ligated into the BamHI–XhoI sites of
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fragment, encoding Pax6.1 without the paired domain, was
ampliﬁedbyPCRfromHA.Pax6DPDusingtheprimerszf.pax6.
HD6-50 and zf.pax6.TAD1-30, and inserted into the SalI–NotI
sites of pENTR11. The pENTR11-Pax6DHD (E101A.E112A.
E120A.E128A) vector was constructed by PCR using the Pfu
polymerase. A 1.0 kb Pax6.1 sequence lacking the homeodo-
main was ampliﬁed from HA.Pax6DHD (E101A.E112A.
E120A.E128A) using the primers zf.pax6.PD7-50 and zf.pax6.
TAD1-30,and ligated into the SalI–NotIsites of pENTR11. All
constructs were veriﬁed by nucleotide sequencing with the
GFP-C1 and GFP-N1 primers (Invitrogen) using the BigDye
v3.1 sequencing kit (Applied Biosystems).
In vitro mutagenesis
PCR-mediated in vitro mutagenesis was performed accord-
ing to the manufacturer’s instructions for the Quick-Change
Site-Directed Mutagenesis kit (Stratagene). Mutagenized con-
structs were veriﬁed by sequencing. The speciﬁc primers used
for mutagenesis are shown in Table 1.
Glutathione S-transferase (GST) pull-down assays
GST fusion proteins puriﬁed from Escherichia coli LE392
or E.coli BL21-Star(DE3)pLysS (Invitrogen) extracts using
glutathione–sepharose beads (Amersham Pharmacia Biotech)
were used in pull-down assays as described previously (21).
Transient transfection assays
NIH 3T3 ﬁbroblasts (passage 123) (ATCC CRL 1658) were
cultured in DMEM supplemented with 10% calf serum
(HyClone, Logan, UT), penicillin (100 U/ml) and 100 mg/ml
streptomycin (Life Technologies, Inc.). About 4 · 104 NIH
3T3 cells/well in 24-well tissue culture dishes were transfected
using LipofectAmine PLUS (Invitrogen). Extracts were pre-
pared 24 h after transfection using the Dual-Light luciferase
and b-galactosidase reporter gene assay system (Tropix) and
analyzed in a Labsystems Luminoskan RT dual injection
luminometer. Transient transfection assays in human HeLa
cells were performed as described previously (21). To probe
expression levels and stability of mutant proteins after trans-
fection, we performed western blots using the following anti-
bodies: rabbit polyclonal anti-GFP (1:1000; Abcam), mouse
Table 1. Sequences of primers used in this study
Name Sequence
Pax6 R53A.30 50-CCTCCATTTCGCTGCTCTGTTTGAGAACC-30
Pax6 R53A.50 50-GGTTCTCAAACAGAGCAGCGAAATGGAGG-30
Pax6 S50A.30 50-CGCTCTTCTGTTTGCGAACCAGACCTG-30
Pax6 S50A.50 50-GACGTCTGGTTCGCAAACAGAAGAGCG-30
Pax6 R58A.30 50-CTTTTCCTCCGCCCTCCATTTCGCTC-30
Pax6 R58A.50 50-GAGCGAAATGGAGGGCGGAGGAAAAG-30
Pax6 N51Q.30 50-CCATTTCGCTCTTCTCTGTGAGAACCAGACC-30
Pax6 N51Q.50 50-GGTCTGGTTCTCACAGAGAAGAGCGAAATGG-30
Pax6 R44A.30 50-GAACCAGACCTGTATTGCTGCTTCTGGTAAATC-30
Pax6 R44A.50 50-GATTTACCAGAAGCAGCAATACAGGTCTGGTTC-30
Pax6 Q46A.30 50-GTTTGAGAACCAGACCGCTATTCTTGCTTCTGG-30
Pax6 Q46A.50 50-CCAGAAGCAAGAATAGCGGTCTGGTTCTCAAAC-30
Pax6 N51A.30 50-CATTTCGCTCTTCTGGCTGAGAACCAGACC-30
Pax6 N51A.50 50-GGTCTGGTTCTCAGCCAGAAGAGCGAAATG-30
Pax6 Q46A.30 50-GTTTGAGAACCAGACCGCTATTCTTGCTTCTGG-30
Pax6 Q46A.50 50-CCAGAAGCAAGAATAGCGGTCTGGTTCTCAAAC-30
Pax6 E120A.30 50-CTGTCTCGGATTGCCCACGCGAAGATTGAC-30
Pax6 E120A.50 50-GTCAATCTTCGCGTGGGCAATCCGAGACAG-30
Pax6 E112A.30 50-GAAGATTGACGGACACGCCCTCTTGTACTG-30
Pax6 E112A.50 50-CAGTACAAGAGGGCGTGTCCGTCAATCTTC-30
Pax6 R57A.30 50-CTTTTCCTCCCTCGCCCATTTCGCTCTTC-30
Pax6 R57A.50 50-GAAGAGCGAAATGGGCGAGGGAGGAAAAG-30
Pax6 E128A.30 50-GTGCAGACCCCCGCTGATAGCAGC-30
Pax6 E128A.50 50-GCTGCTATCAGCGGGGGTCTGCAC-30
Chx10 R57A.30 50-CTTCTCCCTCTTCGCCCACTTGGCTCTG-30
Chx10 R57A.50 50-CAGAGCCAAGTGGGCGAAGAGGGAGAAG-30
Chx10 Q46A.30 50-CTGGAACCACACGCGTATCCTGTCTTCTG-30
Chx10 Q46A.50 50-CAGAAGACAGGATACGCGTGTGGTTCCAG-30
Chx10 R44A.30 50-CCACACCTGTATCGCGTCTTCTGGGAGC-30
Chx10 R44A.50 50-GCTCCCAGAAGACGCGATACAGGTGTGG-30
Chx10 Q50A.30 50-GCTCTGCGGTTCGCGAACCACACCTGTATCC-30
Chx10 Q50A.30 50-GGATACAGGTGTGGTTCGCGAACCGCAGAGC-30
Chx10 N51Q.30 50-CTTGGCTCTGCGTTGCTGGAACCACACCTG-30
Chx10 N51Q.50 50-CAGGTGTGGTTCCAGCAACGCAGAGCCAAG-30
Chx10 R53A.30 50-CCTCCACTTGGCTGCGCGGTTCTGGAACC-30
Chx10 R53A.50 50-GGTTCCAGAACCGCGCAGCCAAGTGGAGG-30
Chx10 R58A.50 30-CAGCACTTCTCCCTCGCCCTCCACTTGGC-30
Chx10 R58A.30 30-GCCAAGTGGAGGGCGAGGGAGAAGTGCTG-30
Pax6 R57Aon
A53.30
50-CTTTTCCTCCCTCGCCCATTTCGCTGCTC-30
Pax6 R57Aon
A53.50
50-GAGCAGCGAAATGGGCGAGGGAGGAAAAG-30
DelB 50-GTAGCTCGAGCTTTCAAACTCTTTTTCA-30
DelC 50-TGGTCTCGAGATTTTTGCAGCAAGTCTTTCTCG-30
zf.pax6-HD1.50 50-CTAGGATCCTGAGGCTTCAGCTTAAA-CGAAAAC-30
zf.pax6-HD1.30 50-TACGAGCTCGGC-TTGTCTTCTTTGATTTCTTAAC-30
zf.pax6-HD2.50 50-GCAGAATTCAGGCTTCAGCTTAAACGAAAACTG-30
zf.pax6-HD2.30 50-AGCGTCGACGGCTTGTCTTCTTTGA-TTTCTTAAC-30
zf.pax6-PD2.50 50-CGACCCGGGTGCAAAACAGTCACAGTGGAGTG-30
zf.pax6-PD2.3 50-TGAGTCGACCTGTTGCTTTTCGCTAG-CCAGG-30
50-SOS 50-CCAAGACCAGGTACCATG-30
50-MYR 50-ACTACTAGCAGCTGTAATAC-30
zf.pax6-HD5.50 50-ACAGAATTCCTCCAATGGCGAGGACTCAGATG-30
zf.pax6-HD5.3’ 50-CGACTCGAGCTGCTGCTGATGGGTATGTGACT-30
zfHD R(-)7A.50 50-GATGAGACCCAAATGGCGCTTCAGCTTAAACG-30
zfHD R(-)7A.30 50-CGTTTAAGCTGAAGCGCCATTTGGGTCTCATC-30
zfHD K(-)3A.50 50-CAAATGAGGCTTCAGCTTGCACGAAAACTGCAAAGG-
AATC-30
zfHD K(-)3A.30 50-GATTCCTTTGCAGTTTTCGTGCAAGCTGAAGCCTCA-
TTTG-30
zfHD R(-)2A.50 50-GAGGCTTCAGCTTAAAGCAAAACTGCAAAGGAATCG-30
zfHD R(-)2A.30 50-CGATTCCTTTGCAGTTTTGCTTTAAGCTGAAGCCTC-30
zfHD K(-)1A.50 50-CTTCAGCTTAAACGAGCACTGCAAAGGAATCGC-30
zfHD K(-)1A.30 50-GCGATTCCTTTGCAGTGCTCGTTTAAGCTGAAG-30
zfHD R(+)3A.50 50-CTTAAACGAAAACTGCAAGCGAATCGCACTTCTTTC-30
zfHD R(+)3A.30 50-GAAAGAAGTGCGATTCGCTTGCAGTTTTCGTTTAAG-30
zfHD R(+)5A.50 50-GAAAACTGCAAAGGAATGCCACTTCTTTCACACAAG-30
zfHD R(+)5A.30 50-CTTGTGTGAAAGAAGTGGCATTCCTTTGCAGTTTTC-30
zfHD K61A.50 50-GGAGGAGGGAGGAAGCGTTAAGAAATCAAAGAAG-30
zfHD K61A.30 50-CTTCTTTGATTTCTTAACGCTTCCTCCCTCCTCC-30
Table 1. Continued
Name Sequence
zfPD.E101A-50 50-GACTCCCGCGGTGGTCGGCAAAATTG-30
zfPD.E101A-30 50-CAATTTTGCCGACCACCGCGGGAGTC-30
zfPD.D123A-50 50-GTGGGCAATCCGAGCCAGGCTGCTAT-30
zfPD.D123A-30 50-ATAGCAGCCTGGCTCGGATTGCCCAC-30
P630Ustopp 50-CTAGCGGCCGCTGTAGTCTGGGCCAGTA-30
FlagDPD.50 50-GCGGAATTCGGGCGCAGATGGCATGTAT-30
Pax6.30NotI 50-ATAGCGGCCGCTCACTGTAGTCTGGGCCA-30
Flag P6.50 50-GACCTCGAGCAAAACAGTCACAGTGGAGTG-30
zf.pax6.HD7-50 50-AGCGGATCCGCATGTATGAAAAGCTGAGGATGCT-30
zf.pax6.TAD2-30 50-GACCTCGAGTCGCGTTCTGCCTGTAGTCTGGG-30
zf.pax6.HD6-50 50-CGAGTCGACTATGAAAAGCTGAGGATGCTGAACG-30
zf.pax6.TAD1-30 50-GACGCGGCCGCTCGCGTTCTGCCTGTAGTCTGGG-30
zf.pax6.PD7-50 50-CGAGTCGACAACAGTCACAGTGGAGTGAACCAG-30
GFP-N1-30 50-CCGTTTACGTCGCCGTCCAG-30
GFP-C1-50 50-GATCACATGGTCCTGCTGGA-30
Nucleic Acids Research, 2005, Vol. 33, No. 8 2663monoclonal anti-HA, clone 12CA5 (1:1000, Roche), afﬁnity-
puriﬁed rabbit polyclonal anti-Pax6 C-terminal P6C (1:800)
(7)antibodiesandperoxidase-conjugatedsecondaryantibodies
(1:2000; Santa Cruz Biotechnology). Detection and quanti-
ﬁcation were performed using ECL chemiluminescence
(Amersham Biosciences) and the LumiAnalyst imager and
software (Roche Applied Sciences).
Yeast two-hybrid assays using the SOS
recruitment system
Yeast two-hybrid assays usingthe SOS recruitment interaction
system was performed essentially as described (36). The
Saccharomyces cerevisiae cdc25-2 MATa strain (ura3-52
his3-200 ade2-101 lys2-801 trp1-901 leu2-3 112 cdc25-2
Gal
+) was co-transformed with 0.3 mg of each pSOS-bait
and pMYR-prey plasmids using the lithium acetate method.
Gel mobility shift assay
GST fusion proteins were puriﬁed from E.coli BL21-
Star(DE3)pLysS extracts as described previously (21). The
proteins were eluted from the beads using 5 mM reduced
glutathione (Sigma). The GST fusion proteins were analyzed
on a 10% SDS–polyacrylamide gel and quantiﬁed using
SYPRO1 Ruby protein stain (Bio-Rad) and LumiAnalyst
imager and software (Roche Applied Sciences). Binding of
GST-Pax6-HD and mutants to the
32P-labeled HDp3 probe
(50-GATCCTCTAGATAATGCGATTAGCGTAG-30) was
performed as described previously (21), with the exception
that 100 mM NaCl was used instead of 30 mM KCl. The
binding reactions were performed in the presence of
100 ng/ml of BSA (Sigma).
Molecular modeling of PD and HD and
their interactions
The ICM Pro 3.0 program (Molsoft L.L.C., La Jolla, CA;
available on the World Wide Web at www.molsoft.com)
(37) was utilized for comparative modeling, computer graph-
ics visualizations, protein–protein docking, energy calcula-
tions and calculation of molecular surfaces and electrostatic
potentials. Astepwise energy reﬁnementof the X-ray structure
of human Pax6 PD [Protein Data Bank code 6pax (38)] was
performed using the regul macro of ICM. Residues from S23
to Q155 of Pax6 are included in the structure. Using the A
proteinchainoftheX-ray structure ofHDfromthe Drosophila
paired protein [Protein Data Bank code 1fjl (39)] as a struc-
tural template and the homology module of ICM, two three-
dimensionalmodelsofthehumanPax6HDwerebuilt,model1
including F8 to N64 and model 2 including L-4 to A73 (num-
bering of HD according to a generic HD numbering scheme).
The reﬁneModel macro of ICM was used to perform stepwise
energy reﬁnement of the HD models. Rigid body docking
simulations of Pax6 PD–HD were performed using the HD
model 1, and low-energy conformations were collected in a
conformational stack for the docking simulation. A stack con-
formation having Arg44, Arg53, Arg57 and Arg58 of the HD
at the PD–HD interface was selected. Extra amino acids at the
N- and C-terminal end of the HD molecule were included by
replacing the HD molecule with model 2 followed by manual
adjustment of a few backbone dihedral angles of the
N-terminal arm in order to introduce interactions between
positively charged residues in HD domain (R3 and R5)
and negatively charged residues of the PD domain. The
model of the PD–HD complex was obtained by energy
minimization using the AMBER 8 force ﬁeld (http://amber.
scripps.edu/).
Fluorescence resonance energy transfer experiments
For FRET microscopy, subconﬂuent HeLa cells ( 1 · 10
4
cell/well) grown in eight-chambered cover slides (Nunc),
were transiently transfected with LipofectAmine PLUS (Invit-
rogen) using 50 ng each of the different CFP- and YFP-tagged
Pax6 expression constructs. FRET analysis was performed
using a Zeiss LSM510 META confocal microscope equipped
with a 25 mW argon laser (Carl Zeiss GmbH, Germany).
FRET was measured using the acceptor photobleaching
method (40,41). Emission of CFP and YFP was detected by
lambda scan from 460 to 600 nm, with 10 nm intervals, using
the META detector. The YFP acceptor was bleached in the
nucleus, by scanning a region of interest (ROI), by 30 itera-
tionsusing95%intensityand45%laserpowerwiththe514nm
Argon laser line. FRET was detected as decreased YFP-
emission and a corresponding increased CFP-emission in
the bleached area. The YFP acceptor was bleached between
images three and four using the 458 nm laser line. We used
cells expressing approximately a 1:1 ratio of the CFP- and
YFP-tagged proteins for FRET experiments and at least 5 cells
(nuclei) per pair of CFP and YFP fusions were analyzed.
RESULTS
The recognition helix (helix 3) of the homeodomain of
Pax6 is required for binding to both the paired
domain and the homeodomain
We have previously shown that the Pax6 homeodomain is able
to bind to other homeodomains, and to the C-terminal sub-
domain of the paired domain (RED) (21). However, the nature
of the interaction surfaces involved is unknown. The homeo-
domain consists of three a-helices. GST pull-down assays
conducted with three different deletion constructs of the
HD in Pax6DPD implicated helix 3 either as (i) directly
required for the protein–protein interactions or as (ii) required
for the formation or positioning of the interaction surface
located elsewhere in the domain (Figure 1A and B). We
next generated four single-point mutations in helix 3. We
chose to mutate surface-exposed residues conserved between
homeodomains we had previously found to interact with Pax6
(21). Thus, S50, R53 and R58 were mutated to alanine while
N51wasmutated toglutamine.Thismutation(N51Q)isrepor-
ted to abolish DNA binding by the paired class homeodomain
protein Phox1 (42). GST pull-down experiments indicated that
N51, R53 and R58 are important for the interaction with Pax6,
while S50 mutated to alanine had no effect on the interaction
between GST-HD and Pax6 (Figure 1C). The same mutations
in helix 3 that reduced the interactions of GST-HD with full-
length Pax6 also reduced the interaction with Pax6DHD and
Pax6DPD (Figure 1C). Although the same amino acids in helix
3 seem to be important for both the interaction with the PD and
the HD, there are differences between these two interactions.
The HD–HD interaction (between GST-HD and Pax6DPD) is
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Pax6DHD). Furthermore, the HD–PD interaction was reduced
to a greater extent by the mutations, than the HD–HD inter-
action. R58 seems to be more important for the HD–HD inter-
action than N51 and R53. For the HD–PD interaction observed
between GST-HD and Pax6DHD, the three mutants bound to
Pax6DHD with a similarly reduced afﬁnity (Figure 1C).
Since we have mapped the protein–protein interaction sur-
face of the HD to the DNA-binding helix 3, it is possible that
the interaction is mediated through DNA. We have earlier
observed that the interaction between Pax6 and Pax6DHD
with GST-HD is DNA-independent because it is not abolished
by the addition of ethidium bromide (21). These results were
conﬁrmed using the nuclease benzonase, which destroys both
DNA and RNA (Figure 1D).
In order to test the PD–HD and HD–HD interactions in
another experimental setting we used the SOS-recruitment-
based yeast two-hybrid system (43). This system is based
on translocation of an active human SOS protein to the
inner leaﬂet of the plasma membrane. In this system, a pos-
sible contribution of nucleic acids to the binding is completely
ruled out. As shown in Figure 1E, both the PD–HD and the
HD–HD interactions were veriﬁed in this system. In addition,
as shown by the GST pull-down assays, the PD–HD interac-
tion appeared stronger than the HD–HD interaction.
Model of the Pax6 PD–HD complex
We next constructed models of human Pax6 PD and HD using
the published structures of the human Pax6 PD bound to DNA
and the HD of Drosophila paired as starting points (38,39).
The model of the Pax6 PD–HD complex shown in Figure 2
features salt bridge interactions between positively charged
residues in helix 3 of the HD and negatively charged residues
in helices 1 and 2 of RED (R44 in HD–E128 in RED, R53 in
HD–E120 in RED and R57 in HD–E120 in RED). The pos-
itively charged side chain of K55 in helix 3 interacts with the
carboxylate group of E112 in helix 1, whereas the side chain
R58 in HD interacts with the main chain carbonyl group of
E112atthe C-terminalendofhelix1inRED.Furthermore,the
side chain NH2 groups of Q46 and N51 in HD interact with the
carboxylate group of D123 (helix 2) and the R124 side chain
(helix 2) in RED, respectively. The side chains of Y25 in HD,
W119 and F117 in RED (residues not shown in Figure 2) are
localized close to salt bridges in the model. The side chain OH
group of S115 in RED (loop between helices 1 and 2) interacts
with the backbone CO group of A54 in HD (helix 3), whereas
Figure 1. The recognition helix of the homeodomain of Pax6 is important for
interaction with both the PD and the HD. (A) Pax6 constructs used for in vitro
translation and GST pull-downs. (B) GST pull-down assays with Pax6 HD and
PD fused to GST and immobilized on glutathione–agarose beads and
Pax6DPDDHD, Pax6DPDDh2–3 or Pax6DPDDh3 produced by in vitro tran-
scriptionandtranslationinthepresenceof[
35S]methionine.Analiquotof10ml
oftheinvitrotranslationreactionswaspreincubatedwithGSTimmobilizedon
glutathione–agarosebeadsbeforeincubationwiththeGSTfusionproteins.The
GSTbeads,GST-Pax6HDbeadsandGST-Pax6PDbeadswerewashedseveral
times before they were boiled in SDS loading buffer and run on a 10% SDS–
polyacrylamidegel.Analiquotof2mloftheinvitrotranslatedproteinswasrun
on the same gel to visualize the signal from 20% of the input. (C) Point muta-
tions in helix 3 of the homeodomain strongly reduce the ability of Pax6 HD to
interactwiththePDandthewild-typeHD.TheN51Q,R53AandR58A,butnot
S50A, mutants impede the HD–PD and HD–HD interactions. GST pull-down
assayswereperformedwithrecombinantGSTfusionsofwildtypeormutantsof
Pax6DHD against in vitro translated, [
35S]methionine-labeled Pax6, Pax6DHD
or Pax6DPD. (D) The interactions between full-length Pax6 and the RED
subdomain and between full-length Pax6 and the HD are independent of
DNA. GST pull-down assays were done with Pax6 HD and RED fused to
GST as in (C). Where indicated, the pull-down experiments were performed
inthepresenceof500UbenzonasetodegradebothDNAandRNA.Theresults
shown are representative of three independent experiments. (E) The PD–HD
and HD–HD interactions of Pax6 are also observed in the yeast-based SOS
recruitment interaction system. The temperature sensitive yeast strain S.cere-
visiaecdc25-2MATawasco-transformedeither withpSOS-zfPax6-HDwtand
empty pMYR or pMYR-LaminC as negative controls, pMYR-SOS binding
protein as a positive control, pMYR-zfPax6-HDwt, or with pMYR-zfPax6-
PDwt.Threeindependentcoloniesgeneratedfromeachco-transformationwere
replica plated onto galactose plates and grown in parallel at 25 and 37 C for
6 days. The results shown are representative of three independent experiments.
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interaction with the backbone CO group of D123 in the same
helix. Residues in the N-terminal arm of HD interact with the
residues in helix 2 (R3 in HD–E128 in RED) and helix 1 (K-1
in HD–E101 in RED, Q2 in HD–K105 in RED and R5 in HD–
E112 in RED) of RED.
Amino acids in the homeodomain important for the
PD–HD interaction
Based on the model for the PD–HD interaction (Figure 2),
we mutated arginines 44 and 57 in the HD to alanine. GST
pull-down experiments showed that R44, R53 and R57 were
all important for the PD–HD interaction (Figure 3). We also
found that the K55A mutation reduced this interaction (data
not shown). The K61A mutation, affecting the basic residue
immediately C-terminal to the HD, had no effect (Figure 3).
Single mutations of R44, R53 and R57 to alanine resulted in
25–50% binding compared with the wild-type HD. The R44A
mutant tends to interact better than the R53A and the R57A
mutants. The combinations of double mutants of R44, R53 and
R57 resulted in a further reduction of binding (10–15%), while
the triple mutant displayed <10% binding.
Basic residues in the N-terminal arm are known to be invol-
ved in protein–DNA interactions of homeodomains (39). As
shown in Figure 3, R3 and R5 are both implicated by alanine
substitutions as contributors to the PD–HD interaction. Single
mutations of the basic residues immediately in front of the HD
Figure 2. Model of the PD–HD interaction surface. (A and B) Energy mini-
mizedmodelofthePax6PD–HDcomplexwithcontactresiduesattheinterface
between the HD and the RED subdomain of the PD displayed. The side chain
interactions involving helix 2 of RED are shown in (A) and those involving
helix1in(B).Colorcodingofribbon:Cyan,RED;Green,HD.Colorcodingof
residues:red,DandE;blue,RandK;andyellow,S,QandN.(C)Electrostatics
surfacepotentialsofthePax6PD(left)andHD(right)colorcodedaccordingto
electrostatic potentials(blue, e > 5 kcal/electronunits; white, 5 < e > 5 kcal/
electron units; and red, e <  5 kcal/electron units). Molecular surfaces
and electrostatics potentials were calculated by using the REBEL (rapid exact
boundary element) methodof ICM forthe HD and the PD. The arrow indicates
that the HD has been rotated relative to the PD to orient its interaction surface
towards the front. The two interacting domains were moved apart to facilitate
visualization of the interacting surfaces.
Figure 3. Arginines (R44, R53 and R57) in the recognition helix and N-
terminal arm (R3 and R5) of the homeodomain of Pax6 are important for
the interaction with the paired domain. GST pull-down assays with Pax6
HD, and HD mutations fused to GST and immobilized on glutathione–
agarose beads and in vitro translated Pax6DHD.(A) The GST pull-downswere
performedasdescribedinthelegendtoFigure1.Thepanelshowstwodifferent
experimentsusingtwodifferentGST-HDfusions.TheGST-HDprotein(upper
panel) contains two amino acids N-terminal to the HD while the GST-18L-HD
(lowerpanel)contains18aminoacidsofthelinkerregionN-terminaltotheHD
to study the effect of mutating also at  3 relative to the start of the HD. (B)
Quantitativerepresentationoftheinteractiondata.AFujiBio-imaginganalyzer
(BAS5000) equipped with Image Gauge version 4.0 software was used to
quantitate
35S-labeled proteins in the SDS–polyacrylamide gels. The amount
35S-labeledPax6DHDpulleddownbywild-typeGST-HDwassetto100%.The
data shown represent the mean of three independent experiments.
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tribute signiﬁcantly to this interaction. Taken together, these
results show that the arginine residues at positions 3, 5, 44, 53,
57 and 58 (Figure 1C), in addition to the lysine at position 55,
are all important for the interaction between Pax6 HD and
Pax6 PD. Furthermore, single mutations do not completely
impair the interaction between GST-HD and Pax6DHD.
Amino acids in the paired domain important for
the PD–HD interaction
The model for the PD–HD interaction implicates ﬁve acidic
residues in the RED subdomain. We ﬁrst mutated the glutam-
ate residues at positions 112, 120 and 128 in the PD to ala-
nines. Mutation of single amino acids did not result in any
reducedbinding betweenHD andPD inGST pull-downassays
(Figure 4). However, when two of the Glu residues were
substituted with alanines the interaction was reduced by
40–60%. Furthermore, mutating all three Glu residues resulted
in only 15% residual binding (Figure 4). The D123 residue,
implicated at the interaction surface in the model in Figure 2,
was studied in the context of a D123A/E128A double mutant.
The PD–HD interaction was inhibited more by this double
mutant than the E128A single mutant suggesting that D123
also contributes to the acidic interaction surface (Figure 4B).
The D123 and the E101 residues were studied in the context of
two quadruple mutants, including the E112, E120 and E128
residues. The results show that E101 also contributes to the
interaction and in the quadruple mutant containing D123A
there is almost no residual binding activity (Figure 4).
Thus, mutation of one amino acid is not sufﬁcient to com-
promise the overall acidity of the interaction surface in the
RED subdomain of the PD. Alternative interactions formed by
one of the neighboring Glu residues probably compensate for
the breakage of salt bridges occurring in single mutants. Dou-
ble and triple mutations result in a substantially lowered acid-
ity as well as breakage of multiple salt bridges. Interestingly,
single mutations in the HD do impair the PD–HD interaction
while single mutations in the PD do not. Double mutants in the
HD give only <20% binding, whereas double mutants in the
PD give 50–60% binding. The triple mutant in the PD binds
with approximately the same afﬁnity as double mutants in the
HD (Figures 3 and 4).
Superactivation of Pax6-mediated transactivation
from paired domain-binding sites by Pax6DPD is
dependent on the integrity of R44, R53, R57 and
R58 in helix 3 of the homeodomain
We have previously shown that Pax6DPD as well as other
homeodomain proteins, such as Rax, Chx10, HoxB1, Pbx1
and Lhx2, can enhance Pax6-mediated transactivation of a
minimal promoter containing consensus Pax6 paired
domain-binding sites in HeLa cells (21). Thus, we used this
assay to test the effect of helix 3 mutations in vivo. HeLa cells
were co-transfected with expression vectors for Pax6 and the
different Pax6DPD constructs with mutations in helix 3 of
the HD together with the reporter plasmid pP6CON-LUC
(Figure 5A). The pP6CON-LUC reporter contains six con-
sensus Pax6 paired domain binding sites upstream of the
adenovirus E1b minimal promoter (12). Pax6DPD does not
bind to the paired domain binding sites, but is able to signi-
ﬁcantly enhance (superactivate) Pax6-mediated transcrip-
tional activation of pP6CON-LUC (21). Completely
consistent with the results from the GST pull-down assays,
the R53A, R57A and R58A mutations resulted in lowered
superactivation of Pax6 by Pax6DPD (Figure 5A). The
R44Amutation didnotresultinloweredsuperactivation, prob-
ably because of the higher afﬁnity for PD than the other
mutants. The S50A mutation resulted in reduced superactiva-
tion in spite of no effect on the afﬁnity of GST-HD for Pax6 as
observed by GST pull-down assays.
In HeLa cells there is a background of endogenous Pax6,
and Pax6DPD can in principle bind not only to the PD but also
to the HD. We, therefore, transfected Pax6DHD together with
mutated Pax6DPD into NIH 3T3 cells that do not express Pax6
(3). Reporter gene assays in NIH 3T3 cells with Pax6DHD and
the same Pax6DPD wild-type and mutant constructs as in
Figure 5A gave similar results as with Pax6 in HeLa cells,
except for the S50A mutant, which did not give any reduced
Figure 4. The acidic residues E101, E112, E120, D123 and E128 in the paired
domain are important for the interaction with the homeodomain of Pax6. GST
pull-downassayswithPax6HDfusedtoGSTandimmobilizedonglutathione–
agarose beads and Pax6DHD protein produced by in vitro transcription and
translation in the presence of [
35S]methionine. (A) The single mutants of
Pax6DHD, E112A, E120A and E128A bind to GST-HD with the same affinity
as the wild type. For the double mutants the binding to the homeodomain was
reduced by 40–60%. The triple mutant displays only 15% residual binding
while the quadruple mutants showed 11 and 5% binding, respectively. The
GST pull-downs were performed as described in the legend to Figure 1.
(B) Quantitative representation of the interaction data determined as described
in the legend to Figure 3. The data shown represent the mean of three
independent experiments.
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the data presented above from the superactivation experiments
in cells conﬁrm the in vitro interaction data underscoring the
importance of the Arg residues (R44, R53, R57 and R58) in
helix 3 of the HD for the HD–PD interaction. None of the
mutations introduced in helix 3 affected expression levels and
stability of the proteins (Figure 5D).
Having established the importance of the Arg residues in
helix3oftheHDforthe HD–PD interactionwe nextexamined
the effect of mutating the acidic interaction surface of the
RED subdomain of the PD in the superactivation assay. As
shown in Figure 5C, the Pax6DHD(E112A/E120A/E128A)
triple mutant was superactivated by Pax6DPD at lower
efﬁciency than the wild-type Pax6DHD. For the two quadruple
Figure 5. Mutation of Arg residues in helix 3 of the homeodomain impair superactivation of Pax6-mediated transactivation from paired domain binding sites.
(A)EffectofhomeodomainmutantsonsuperactivationofPax6inHeLacells.HeLacellswereco-transfectedwith0.25mgofpCI-Pax6and0.5mgofeitherpcDNA3-
HA,HA-Pax6DPDorHA-Pax6DPDmutants,togetherwith0.5mgoftheluciferasereporterplasmidpP6CON-LUCand0.05mgofthecontrolplasmidpCMVb-gal.
(B) Effectofhomeodomain mutantsonsuperactivationofPax6DPDin NIH3T3cells.NIH 3T3cells wereco-transfectedwith5 ngofPax6DHD and75 ngofeither
pcDNA3-HA,Pax6DPDorPax6DPDmutants,togetherwith50ngpP6CON-LUCand5ngpCMVb-gal.(C)Reducedsuperactivationofthetripleandthequadruple
paired domain mutants of Pax6DHD. NIH 3T3 cells were co-transfected with 50 ng pP6CON-LUC, 5 ng pCMVb-gal, 5 ng of either pcDNA3-HA, Pax6DHD,
Pax6DHD(E112A/E120A/E128A), Pax6DHD(E112A/E120A/D123A/E128A) or Pax6DHD(E101A/E112A/E120A/E128A) together with 75 ng pcDNA3-HA or
Pax6DPD. (D) Western blot showing similar expression levels of wild type and all helix 3 mutants of Pax6DPD after transfection of HeLa cells. Transfection
efficiencies were probed by co-transfecting an EGFP expression plasmid and developing the blot with an anti-GFP antibody. (E) Western blot showing similar
expressionlevelsofwild-type,tripleandquadruplemutantsinthePDofPax6DHD.(F)GelmobilityshiftassaywithGSTfusionsofthePDofPax6wildtype(WT),
triple (T) and quadruple mutants (Q1 = E101A/E112A/E120A/E128A and Q2 = E112A/E120A/D123A/E128A) of Pax6 using a double-stranded oligonucleotide
containing a single P6CON PD binding site as probe. The data shown (A–F) are representative of at least two other independent experiments.
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are included, superactivation was severely compromised
(Figure 5C). These PD mutants were expressed at similar
levels as the wild-type Pax6DHD protein (Figure 5E). The
alanine mutations in the RED subdomain do not impair the
structure of the PD since the quadruple mutants transactivate
the reporter gene just as well as the wild type. As analyzed
by gel mobility shift assays of GST–PD fusion proteins
these mutants bind to the P6CON binding site although
with somewhat reduced afﬁnity compared with wild type
(Figure 5F).
The HD protein Chx10 interacts with the acidic
patch of the paired domain of Pax6 via Arg residues
in helix 3
Our ﬁnding that several different homeodomain proteins
with distinct TADs are able to superactivate Pax6 argues
against a common interaction surface outside of the homeo-
domain in Pax6DPD. We, therefore, chose to study the inter-
action between the HD of the paired-type homeodomain
protein Chx10 and the PD of Pax6. Chx10 and Pax6 are
co-expressed in early retinogenesis and in the spinal cord
(44–46). Chx10 is also able to strongly superactivate Pax6 in
HeLa cells (21). As shown in Figure 6A, the HD of Chx10
interacts much more poorly with Pax6DHD(E112A/E120A/
E128A) than with wild-type Pax6DHD in a GST pull-down
assay. Consistently, Chx10 was not able to superactivate
Pax6DHD(E112A/E120A/E128A) in NIH 3T3 cells while
co-transfection of Chx10 enhanced wild-type Pax6DHD-
mediated transactivation of the P6CON-LUC reporter 3.5-
fold (Figure 6B). Chx10 did not activate the P6CON-LUC
reporter by itself. Thus, Chx10 is clearly dependent on the
acidic interaction surface in the RED subdomain to super-
activate Pax6DPD.
As observed for Pax6, the Chx10 homeodomain mutations,
N51Q, R53Aand K58A, have profoundnegative effects onthe
PD–HD interaction as observed in GST pull-down assays
(Figure 7A). The R44A mutation resulted in 50% binding
while Q46A and Q50A mutations did not have any signiﬁcant
effects. In contrast to Pax6, the R57A mutation did not reduce
the interaction between the Chx10 HD and the Pax6 PD
(Figure 7B). Co-transfection of Chx10 and Pax6DHD resulted
in more than 40-fold superactivation of Pax6DHD-mediated
transcriptionalactivationofthe P6CON-LUCreporterinHeLa
cells (Figure 7C). Chx10 alone is unable to activate P6CON-
LUC. The R44A, N51Q and R53A mutations completely
abolished superactivation while the R57A mutant showed
a strongly reduced superactivation. The Q46A mutant does
not affect the superactivation, while the Q50A and K58A
mutants resulted in 50% reduction of superactivation. All
mutants were expressed at similar levels as wild-type Chx10
(Figure 7D).
The main difference between the helix 3 mutations in Pax6
and Chx10 observed in the superactivation assay is at position
44. The Chx10 R44A mutant shows complete loss of super-
activation while the corresponding Pax6 mutation seemingly
has no effect. However, as described above, when the Pax6
R44A mutation was combined with R53A or R57A a reduced
superactivation was observed compared with the R53A or the
R57A single mutants.
FRET between Pax6 molecules in nuclei of living
cells depends on a PD–HD interaction
The results from the superactivation assays are strongly sug-
gestive of a direct interaction between the PD and the HD of
Pax6 in the nuclei of transfected cells. To test this directly
in the nuclei of living cells we performed FRET experi-
ments using acceptor photobleaching (40,41). With the cyan
and yellow variants of enhanced green ﬂuorescent protein
(CFP and YFP, respectively), as donor and acceptor pair,
FRET occurs only within a distance of 100 s (47). We
co-transfected expression constructs for different CFP and
YFP fusions of Pax6 into HeLa cells and performed acceptor
photo bleaching experiments of ROIs encompassing the nuclei
of cells expressing the donor and the acceptor ﬂuorophores at
similar levels. If the CFP and the YFP fusion proteins are in
close proximity to allow FRET the CFP ﬂuorescence increases
in the region where YFP is bleached. As shown in Figure 8A,
FRET was readily observed in the entire nuclei of cells expres-
sing CFP and YFP fusions of full-length Pax6 (CFP-Pax6 and
Pax6-YFP). FRET was also seen between CFP-Pax6DHD and
Figure 6. Reduced superactivation of the paired domain mutant Pax6D
HD(E112A/E120A/E128A) by the paired-class homeodomain protein
Chx10. (A) The Pax6DHD(3E/A) triple mutant show reduced binding to the
homeodomain of Chx10. GST pull-down assays with the HD of murine Chx10
fusedtoGSTandimmobilizedonglutathione–agarosebeadsandPax6DHDand
Pax6DHD(3E/A) protein produced by in vitro transcription and translation in
the presence of [
35S]methionine. The GST pull-downs were performed as
described in the legend to Figure 1. (B) NIH 3T3 cells were co-transfected
with5ngofeitherpcDNA3-HAvector,HA-Pax6DHDorHA-Pax6DHD(3E/A)
expression vectors together with vector control or increasing amounts of
HA-Chx10 expression vector (5, 25 and 100 ng). An aliquot of 50 ng of the
pP6CON-LUC reporter vector and 5 ng of the CMV bgal vector were used.
The data are shown as fold superactivation compared with Pax6DHD and
empty vector control. The data are representative of two other independent
experiments.
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(Figure 8B and C). However, no FRET could be observed
when CFP-Pax6DPD(R53A,R57A) carrying mutations in two
arginine residues in helix 3 of the HD, which are crucially
involved in the PD–HD interaction, was co-transfected
with Pax6-YFP (Figure 8D). The same was the case when
Pax6DHD(4E/A)-YFP,with fourofthe ﬁveglutamateresidues
oftheacidicinteractionsurfaceoftheREDsubdomainofthePD
substituted with alanines, was co-transfected with CFP-Pax6-
HD (Figure 8E). Taken together, the results from the FRET
experiments strongly support the existence of a PD–HD
inter-molecular interaction between Pax6 molecules in living
cell nuclei involving basic residues in helix 3 and the acidic
patch of the RED subdomain of the PD.
DNA binding of homeodomain mutants
We next tested the DNA-binding activity of mutants in helix
3 of both Pax6 and Chx10 using gel mobility shift assays
(Figure 9A and B). As previously reported for the paired
class HD protein Phox1 the N51Q mutant did not bind
DNA (42). Neither did the R53A mutant of both Pax6 and
Chx10 while the R44A mutant bound weakly (Chx10) or not
at all (Pax6) to the HDp3 probe (Figure 9A and B). A faint
band was observed for the S50A mutant of Pax6 whereas the
corresponding Q50A mutant of Chx10 bound strongly. For the
basic residues at positions 57 and 58, the mutants bound
strongly to DNA with K58A of Chx10 binding more weakly
than the others. As can be suspected from the different mobil-
ities of the protein–DNA complexes in Figure 9A and B,
we found that, contrary to Pax6, Chx10 did not bind to the
palindromic DNA-binding site as a dimer but bound as a
monomer (data not shown).
We also analyzed transactivation of the HDp3LUC reporter
by mutants of Pax6DPD and Chx10 after transient transfection
of HeLa cells (Figure 9C and D). Pax6DPD activated the
HDp3LUC reporter >2-fold in co-transfection experiments
in HeLa cells (Figure 9C). The same was the case for the
DNA-binding R57A and R58A mutants whereas the R44A,
S50A, N51Q and R53A mutants did not show any signiﬁcant
transactivation. Of these, only S50A showed some residual
DNA-binding activity. These results correlate very well with
the DNA-binding results.
Chx10 was able to activate the HDp3LUC reporter >15-fold
when co-transfected in HeLa cells (Figure 9D). As found for
Pax6, R44A, N51Q and R53A were completely unable to
transactivate the reporter gene. The R57A and K58A mutants
activated the reporter 4- and 10-fold, respectively (Figure 9D).
TheR57Amutant bound strongly tothe HDp3 sitewhereas the
K58A mutant bound a bit more weakly than the wild-type
Chx10 HD. Although the same amount of protein was used
in all gel mobility shift assays differential stability of the
different mutant proteins could possibly affect the result.
Thus, some mutants give stronger signals than the wild-type
GST-HD fusion proteins.
DISCUSSION
We have now shown that the DNA recognition helices of the
homeodomains of Pax6 and Chx10 are involved in mediating
binding to the RED subdomain of the paired domain of Pax6.
Figure 7. Mutationofbasic aminoacids in helix3 ofthe Chx10 homeodomain
leads to reduced interaction with and superactivation by Pax6DHD. (A) GST
pull-down assays with Chx10 HD wild type and mutants fused to GST and
immobilized on glutathione–agarose beads and Pax6DHD protein produced by
in vitro transcription and translation in the presence of [35S]methionine. (B)
Quantitative representation of the interaction data determined as described in
the legend to Figure 3. (C) Effects of mutations in the recognition helix of the
HD of Chx10 on superactivation of Pax6DHD-mediated transactivation from
paired domain-binding sites. HeLa cells were co-transfected with 0.5 mg
Pax6DHD, 0.5 mg pP6CON-LUC and 5 ng pCMV-bgal together with either
0.25 mg pcDNA3-HA vector, HAChx10 or HA-Chx10 mutants. HA-Chx10
co-transfectedwiththeemptyPax6DHDcontrolvectorshowsthatChx10alone
doesnotactivatetheP6CONLUCreporter.Thedatain(B)and(C)representthe
mean of three independent experiments. (D) Western blot showing similar
expression levels of wild type and all helix 3 mutants of Chx10 following
transfection of HeLa cells. EGFP served as transfection control.
2670 Nucleic Acids Research, 2005, Vol. 33, No. 8Figure 8. The paired domain and homeodomain of Pax6 interact directly with each other, as analyzed by using FRET. The CFP- and YFP-tagged Pax6 proteins
indicated in (A–E) were co-expressed in human HeLa cells. The cell images are visualized in pseudocolors before and after acceptor photobleaching to highlight
changes in fluorescence intensity. Images of CFP and YFP fluorescence were obtained using the 458 nm laser line. The YFP acceptor was bleached in the whole
nucleususingthe514nmlaserline.FRETwasdetectedasdecreasedYFP-emissionat532nmandacorrespondingincreasedCFP-emissionat479nminthebleached
area. (A) Full-lengthPax6proteins homodimerize in the nucleusof livingcells.(B) The paired domainof Pax6DHD interactsdirectly withthe homeodomain of the
paired-less isoform Pax6DPD. (C) FRET analysis demonstrates interactions between the homeodomain of Pax6DPD and the paired domain of the full-length Pax6
isoform.(D)Mutationsofarginineresiduesinhelix3ofthehomeodomainofPax6impairtheinteractionwiththepaireddomain,asdemonstratedbynovisibleFRET
between the HD double mutant R53A/R57A of Pax6DPD and the PD of full-length Pax6. (E) No FRET was detected between CFP and YFP in cells expressing a
quadruplemutationinthepaireddomainofPax6DHD-E101A/E112A/E120A/E128Aandthewild-typehomeodomainofPax6.Cellsexpressingapproximatelya1:1
ratio of the CFP- and YFP-tagged proteins were used for FRET experiments.
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that can operate both intra- and inter-molecularly. In the latter
case, both the paired-less isoform of Pax6 itself and other co-
expressed homeodomain proteins may contribute to the regu-
lation of gene expression by binding to the paired domain of
full-length Pax6. Through this interaction Pax6 may also
inhibit DNA binding by other homeodomain proteins. By
combining alanine-substitution mutagenesis and molecular
modeling with protein–protein interaction assays we are
able to propose a model where the PD–HD interaction is
largely mediated by electrostatic forces between basicresidues
in helix 3 of the HD and acidic residues in helices 1 and 2 of
the RED subdomain of the PD. As summarized in Figure 10,
the basic residues at positions 57 and 58 of homeodomain
helix 3 of Pax6 are important for protein–protein interaction,
but not for DNA binding. For Chx10, both the R57A and
K58A mutants bound DNA. The K58A mutation reduced
superactivation to 50% and showed very weak interaction
in the GST pull-down assay while R57A showed strongly
reduced superactivation but bound as wild type in GST
pull-down assays. The basic residues R44, R53, K55, R57
and R58 of Pax6 lie on one side of helix 3 (Figures 2 and
10B). R53 is important for both DNA binding and protein–
protein interaction. R44 is important for DNA binding and the
R44A mutants also show some reduction in protein–protein
interaction. This is consistent with both residues being
involved in forming phosphate backbone contacts upon bind-
ing to DNA (39). N51 of the HD is involved in base-speciﬁc
contacts in the major groove of the DNA (39). To our surprise,
the N51Q mutant not only abolished DNA binding but also
protein–protein interactions (Figure 10A). In contrast, the
N51A mutant did not affect protein–protein interactions
Figure 9. DNAbindingandtransactivationfromhomeodomain-bindingsitesofrecognitionhelixmutantsofPax6andChx10.(A)GelmobilityshiftassayofGST-
Pax6wild-typeandhelix3mutants.EqualamountsofGST-Pax6HD andHDmutantswereusedingelmobilityshiftassaysasdescribedinMaterialsandMethods.
The Q46A mutant was included as a control of a mutant that does not affect protein–protein interaction. (B) Gel mobility shift assay of GST-Chx10 HD and HD
mutants.(C)TranscriptionalactivationofPax6DPDwild-typeandHDmutantsfromtheHDp3homeodomain-bindingsiteinthereporterHDp3LUC.HeLacellswere
co-transfected with 0.5 mg HDp3LUC reporter, 50 ng of the control plasmid pCMV b-gal and either 0.5 mg of expression vector for HA-Pax6DPD wild-type, HD
mutantsortheemptypcDNA3-HAvector.Pax6DPDgives>2-foldtransactivationoftheHDp3LUCreporter.(D)TranscriptionalactivationofChx10wild-typeand
HD mutants from the HDp3 site. HeLa cells were co-transfected as in (C) except that 0.5 mg of expression vectors for HA-Chx10 or Chx10 HD mutants were used
instead of expression vectors for HA-Pax6DPD. Chx10 shows 18-fold transactivation of the HDp3LUC reporter. The data in (A–D) are representative of two other
independent experiments.
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to a longer side chain can explain why the PD–HD interaction
is lost in the N51Q mutant.
In addition to basic residues in helix 3, the arginines at
position 3 and 5 in the N-terminal arm of the HD are also
involved in binding to the PD. Molecular modeling suggest
that R3 may interact with E128 and R5 to E112 in the RED
subdomain. In the crystal structure of the Drosophila Prd
cooperative HD dimer bound to DNA both these residues
are involved in DNA binding. R3 is also involved in an
inter-molecular electrostatic interaction with E42 of helix 3
in the other HD (39).
Our results suggest the presence of an acidic interaction
surface in the RED subdomain of the Pax6 PD consisting
of the ﬁve residues E101, E112, E120, D123 and E128.
When four of these residues were substituted with alanines
FRET was abolished and superactivation severely inhi-
bited. Pax6DHD with the triple mutation E112A/E120A/
E128A in the PD still showed a signiﬁcant superactivation
in transient transfection assays. We also observed a weak
FRET with this mutant fused to YFP and tested against
CFP-Pax6 (data not shown) whereas Pax6 constructs with
four of the acidic residues mutated did not display any
FRET (Figure 8E).
Directly relevant to our mapping of an interaction surface
in the RED subdomain is the reported binding of the basic
helix–loop–helix transcription factor microphthalmia (Mitf)
to the RED subdomain of Pax6 (25). A triple mutant of quail
Pax6, corresponding to zebraﬁsh S115A, F117N and E120Q,
resulted in a strongly reduced interaction with Mitf. Interest-
ingly,wehaveimplicatedE120aspartoftheinteractionsurface
inthePD–HDinteraction.InourmodelthesidechainOHgroup
ofS115interactswiththebackboneCOgroupofA54intheHD
and the side chain of F117 is close to the salt bridge between
R57 and E120. We found that the S115A/F117N/E120Q triple
mutant behaved as the double mutants E112A/E120A and
E112A/E128A in GST pull-down assays (data not shown).
Thus, the interaction surfaces in the RED subdomain used by
the homeodomain and Mitf are at least partially overlapping.
While most HDs bind DNA as a monomer, the paired class
HDs bind cooperatively as homodimers to palindromic
DNA-binding sites (16,39). The HDp3 site contains two pal-
indromic TAAT half sites separated by three nucleotides
(TAATGCGATTA). Surprisingly, we found that Chx10
binds as a monomer to the HDp3-binding site (Figure 9B
and data not shown). A binding site selection assay for Chx10
DNA-binding sites yielded an 8 bp consensus, TAATTAGC
(48). This binding site differs from that of other paired class
Figure 10. Summary of the behavior of point mutants in the recognition helix of Pax6 and Chx10 HD in protein binding (PD–HD interaction), superactivation and
DNA-binding assays. (A) The results from GST pull-down assays of PD–HD interactions (see Figures 1, 3 and 7), superactivation of Pax6DHD-mediated
transactivation of the P6CONLUC reporter (see Figures 5B and 7C) and gel mobility shift assays of DNA binding (see Figure 9A and B) are summarized. Note
that except for the N51Q mutant all the other mutants are alanine substitutions. The results are scored as follows: +++, no reduction compared with wild type; ++,
reduced; +, strongly reduced;  , no binding or superactivation; n.d., not determined. (B) The recognition helix of the Pax6 HD is shown with the side chains of the
relevantaminoacidsindicated.Below,thesequenceofthishelixisshownwithasterisksindicatingpositionswherealaninesubstitutionsnegativelyaffectthePD–HD
interactionand/orDNAbinding.NotethattheN51AmutationdoesnotaffectthePD–HDinteractionincontrasttotheN51Qmutationshownin(A).Opensquares,no
effect of alanine substitutions. The arrowhead indicates the location of the N-terminal end of helix 3.
Nucleic Acids Research, 2005, Vol. 33, No. 8 2673HDsinhaving onlyonecentralATTA motif. This supportsour
ﬁnding of monomeric binding to the HDp3 motif.
A few residues in helix 3 of other HD proteins have been
implicated in protein–protein interactions. The Axenfeld–
Rieger Syndrome mutation, K50E, in the HD of PITX2a
leads to increased dimerization of PITX2a in solution (49).
In our case the S50A mutation did not affect the PD–HD
interaction of Pax6. The Csx/Nkx2.5 homeodomain protein
provides another example of a HD protein that is able to
homodimerize on DNA (and in solution). K57 and R58
near the C-terminal end of helix 3 are critical for the dimer-
ization (50). K57 was also found to be important for the inter-
action with the zinc ﬁnger transcription factor GATA 4 (50).
Our observation that R57 and R58 are important for the PD–
HD interaction of Pax6 underscores the role these residues
have in protein–protein interactions. A recent report demon-
strates that geminin, a protein involved in the inhibition of the
licensing of DNA replication, interacts with several Hox pro-
teins in yeast two-hybrid and GST pull-down experiments
(51). Using a Hoxa11 peptide array, amino acids 54–58 in
addition to the ﬁrst amino acids of the HD were found to
be important for this interaction. Thus, similar to our ﬁndings,
both helix 3 and the N-terminal arm of the HD are implicated
in a speciﬁc protein–protein interaction.
The biological relevance of the interaction studied here is
as a mechanism for intra- and inter-molecular modulation of
Pax6-mediated gene regulation. Evidence for an interdepend-
ence of the functionality of the PD and HD of both Pax6 and
Pax3 has been reported (20,21,52–55). This interdependency
could at least to a certain extent be a reﬂection of an intra-
molecular PD–HD interaction. Additionally, co-expressed
homeodomain proteins may modulate Pax6-mediated gene
regulation by binding to the RED subdomain of DNA-
bound Pax6 without binding to DNA themselves. Pax6
may inhibit the DNA-binding activity of co-expressed HD
proteins by binding to their recognition helix as recently
shown for the geminin–Hoxa11 interaction (51). In line with
this notion experiments where an oligonucleotide containing
the HDp3-binding site was added in increasing amounts
to GST pull-down assays revealed competition between
GST-HD binding to Pax6DHD or to the DNA-binding site
(J. A. Bruun, E. I. S. Thomassen, T. Holm and T. Johansen,
unpublished data). In a very recent paper Pax6 was shown to
interact with the homeodomain protein Vax and with Tbx5 to
establish the dorsoventral boundary of the developing eye
(56). Very interestingly, Vax binds to the PD and HD of
Pax6 and represses Pax6 transactivation. Furthermore, over-
expression of either the PD or the HD of Pax6 is sufﬁcient to
dorsalize the eye in chicken suggesting that protein–protein
interactions are involved in eye dorsalization (56). Thus, the
PD–HD interaction we have characterized is highly relevant to
mechanisms involved in determining gene expression bound-
aries. In conclusion, our studies show that helix 3 in the HD of
Pax6 and other paired class HD proteins can act as a speciﬁc
recognition helix for both DNA- and protein-binding.
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